XML 25 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIENCY) - USD ($)
Series A Preferred
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2016 510,000 120,825,134      
Beginning Balance, Amount at Dec. 31, 2016 $ 5,100 $ 1,208,252 $ 41,367,946 $ (34,331,233) $ 8,250,063
Equity based compensation     635,223   635,223
Common stock issued for services provided, Shares   249,824      
Common stock issued for services provided, Amount   $ 2,498 35,602   38,100
Warrants exercised, Shares   975,000      
Warrants exercised, Amount   $ 9,750 39,000   48,750
Warrants issued as part of debt private placement     61,904   61,904
Induced Conversion Costs         0
Net Loss       (3,639,814) (3,639,815)
Ending Balance, Shares at Dec. 31, 2017 510,000 122,049,958      
Ending Balance, Amount at Dec. 31, 2017 $ 5,100 $ 1,220,500 42,139,675 (37,971,049) 5,394,225
Equity based compensation     31,522   31,522
Common stock issued for services provided, Shares   362,500      
Common stock issued for services provided, Amount   $ 3,625 33,875   37,500
Conversion of Notes Payable and Accrued Interest into Common Stock, Shares   1,877,960      
Conversion of Notes Payable and Accrued Interest into Common Stock, Amount   $ 18,780 686,432   705,212
Warrants exercised, Amount         0
Induced Conversion Costs     57,201   (57,201)
Net Loss       (3,230,462) (3,230,462)
Ending Balance, Shares at Dec. 31, 2018 510,000 124,290,418      
Ending Balance, Amount at Dec. 31, 2018 $ 5,100 $ 1,242,904 $ 42,948,705 $ (41,201,511) $ 2,995,198